Search

You searched for "cleft"

2259 results found

A small company’s perspective

1 March 2015 | ENTA - General
In this article, we hear from Alan McNulty, Director from Sheffmed, an SME (Small – Medium Enterprise), who have supplied surgical instruments, consumables and video systems to ENT clinicians for over 12 years. Alan outlines some of the choices and...

Military otolaryngology and its impact on civilian trauma care

1 July 2014 | | ENTA - Head & Neck, ENTA - Laryngology / Swallowing / Voice, ENTA - Otology
Over the centuries, military conflicts and wars have caused both death and injuries and led to improvements in the care of the combat wounded. Military otolaryngologist-head and neck surgeons have been at the forefront of these developments and advances. War...

Head and neck cancer awareness

1 March 2016 | | ENTA - Head & Neck
Head and neck cancer is one of the most preventable cancers, and awareness and screening campaigns have shown a decline in its incidence. Support for campaigns of awareness and education about these cancers is crucial from professional, societal and governmental...

When patient choice stands in the way of patient-centredness

1 July 2015 | | ENTA - Audiology - Adult
In the field of hearing care, there is increasing focus on ensuring patient autonomy and choice. Greater participation in decision making is supposed to result in better patient satisfaction. A study conducted in ENT and audiology clinics paradoxically suggests that...

Cognitive spare capacity: what is it and why does it matter?

26 June 2017 | | ENTA - Audiology - Adult, ENTA - Neurotology
Cognition refers to thinking and memory. So why would cognition be a useful concept for ENTs and audiologists? Audition provides our main channel of communication and when we speak to each other, we want to exchange thoughts and remember what...

Aspirin desensitisation for aspirin-exacerbated respiratory disease (AERD)

2 March 2022 | | ENTA - Rhinology / Sinus
In this article, the authors describe the importance of identifying aspirin-exacerbated respiratory disease in patients with chronic rhinosinusitis refractory to standard medical treatment. This can then open the door to considering aspirin desensitisation treatment which, in their hands, has proven...

Head and neck cancer deaths to cost $535 billion by 2030

3 March 2021 | | ENTA - Head & Neck
More than 500,000 people across the globe will die this year from head and neck cancer, which is the sixth most common cancer in the world and comprises malignancies of the nose, mouth, throat, larynx, and neck. Assuming current trends...

MedShr for ENT and audiology: clinical case discussion on the go

7 July 2020 | | ENTA - Audiology - Adult
The COVID-19 pandemic has changed all aspects of our lives – not least medical education. With isolation being the buzzword at the moment, the internet and social media are popular sources for official and crowd-sourced content. In this article, Samantha...

Hyposalivation: a review of current and future treatments

8 January 2024 | | ENTA - Head & Neck
Hyposalivation remains a stubbornly difficult condition to treat, but novel therapies may not be far away. Saliva has many essential functions, including aiding digestion and swallowing, lubrication, maintaining tooth integrity and antibacterial activity. When patients experience reduced saliva production (hyposalivation),...

Lies, damned lies and relative risk reduction

4 September 2023 | | ENTA - ENT
Chris Potter has a thing or two to say about the use of statistics and, in doing so, he takes us to a Friday night steak house that is prone to airway disasters and on a short tour of his...

When dinosaurs ruled the earth

2 September 2022 | | ENTA - ENT
Optimism is abundant in medical research, but frequently ends up being tempered with reality. In his inimitable style, Chris Potter looks back over his career – starting with his medical school memories of Bentley-driving ENT consultants, and moving forward through...

2014: Are today’s implantable devices better than conventional solutions for patients with conductive or mixed hearing loss?

6 June 2017 | | ENTA - Audiology - Adult, ENTA - Audiology - Paediatric, ENTA - Audiology - Auditory Implants, ENTA - Otology, ENTA - Paediatrics
Patients with conductive or mixed hearing loss become candidates for amplification when reconstructive surgery is not viable. Three common amplification options are conventional acoustic devices, such as behind-the-ear devices (BTEs), (implantable) bone-conduction devices and active middle ear implants. The goal...